Literature DB >> 24826395

Midterm results of radiofrequency ablation for incompetent small saphenous vein in terms of recanalization and sural neuritis.

Jae Young Park, Azimbaev Galimzahn, Hyung Sub Park, Young Sun Yoo, Taeseung Lee.   

Abstract

BACKGROUND: Safety and effectiveness of radiofrequency ablation for incompetent small saphenous vein is not established.
OBJECTIVE: To report midterm clinical and ultrasonograhic results of radiofrequency ablation (RFA) for small saphenous vein (SSV) in terms of recanalization and sural neuritis. METHODS AND MATERIALS: We examined 39 patients (46 limbs) who had been examined using a duplex scan more than 1 year after RFA of SSV. Postoperative clinical results, risk factors for SSV recanalization, and sural neuritis were analyzed.
RESULTS: CEAP score and CIVIQ2 score improved significantly in all patients (CEAP: 2.45 to 1.43 (p = .03); CIVIQ2: 25.34 to 13.21 (p = .01). SSV obliteration rate was 93.4% at 1 year and 89.1% at 2 years. Preoperative peak reflux velocity in the recanalization group (54.9 cm/s) was significantly higher (p < .01) than in the obliteration group (29.8 cm/s). Sural neuritis were detected in 12 limbs(26.1%), and median symptom duration was 3 months. The total length of RFA ablation was not different between the groups with and without postablation sural neuritis.
CONCLUSION: RFA is an effective and safe treatment modality for incompetent SSV. Peak reflux velocity can be a risk factor for recanalization. Length of RFA segment in SSV does not affect recanalization and postablation sural neuritis.
© 2014 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 24826395     DOI: 10.1111/dsu.12456

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  1 in total

1.  Comparison of Endovenous Laser and Radiofrequency Ablation in Treating Varices in the Same Patient.

Authors:  Orhan Bozoglan; Bulent Mese; Erdinc Eroglu; Hasan Cetin Ekerbiçer; Alptekin Yasim
Journal:  J Lasers Med Sci       Date:  2017-01-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.